BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21487409)

  • 21. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic lupus and malignancies.
    Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
    Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers.
    Wilson KM; Mucci LA; Rosner BA; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2503-15. PubMed ID: 20693310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diet and risk of breast, endometrial and ovarian cancer: UK Women's Cohort Study.
    Dunneram Y; Greenwood DC; Cade JE
    Br J Nutr; 2019 Sep; 122(5):564-574. PubMed ID: 30526696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Barry JA; Azizia MM; Hardiman PJ
    Hum Reprod Update; 2014; 20(5):748-58. PubMed ID: 24688118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A healthy lifestyle index and its association with risk of breast, endometrial, and ovarian cancer among Canadian women.
    Arthur R; Kirsh VA; Kreiger N; Rohan T
    Cancer Causes Control; 2018 Jun; 29(6):485-493. PubMed ID: 29667103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
    dos Santos Silva I; Swerdlow AJ
    Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
    Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.
    Lerner-Geva L; Rabinovici J; Olmer L; Blumstein T; Mashiach S; Lunenfeld B
    Gynecol Endocrinol; 2012 Oct; 28(10):809-14. PubMed ID: 22475084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
    Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
    Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
    Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
    Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
    Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
    Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trans-ethnic Mendelian randomization study of systemic lupus erythematosus and common female hormone-dependent malignancies.
    Zhu T; Ding Y; Xu X; Zhang L; Zhang X; Cui Y; Liu L
    Chin Med J (Engl); 2023 Nov; 136(21):2609-2620. PubMed ID: 37027287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An international cohort study of cancer in systemic lupus erythematosus.
    Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
    Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer in systemic lupus.
    Bernatsky S; Ramsey-Goldman R; Petri M; Urowitz MB; Gladman DD; Fortin PR; Ginzler E; Romero-Diaz J; Peschken C; Jacobsen S; Hanly JG; Gordon C; Nived O; Yelin EH; Isenberg D; Rahman A; Bae SC; Joseph L; Witte T; Ruiz-Irastorza G; Aranow C; Kamen D; Sturfeldt G; Foulkes WD; Hansen JE; St Pierre Y; Raymer PC; Tessier-Cloutier B; Clarke AE
    Lupus; 2017 Mar; 26(3):311-315. PubMed ID: 27687028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus.
    Cobo-Ibáñez T; Urruticoechea-Arana A; Rúa-Figueroa I; Martín-Martínez MA; Ovalles-Bonilla JG; Galindo M; Calvo-Alén J; Olivé A; Fernández-Nebro A; Menor-Almagro R; Tomero E; Horcada L; Uriarte-Itzazelaia E; Martínez-Taboada VM; Andreu JL; Boteanu A; Narváez J; Bohorquez C; Montilla C; Santos G; Hernández-Cruz B; Vela P; Salgado E; Freire M; Hernández-Beriain JÁ; Díez-Álvarez E; Expósito L; Fernández-Berrizbeitia O; Velloso-Feijoo ML; Ibáñez-Barceló M; Lozano-Rivas N; Bonilla G; Moreno M; Raya E; Quevedo-Vila VE; Vázquez-Rodríguez TR; Ibáñez-Ruan J; Muñoz-Fernández S; Sánchez-Alonso F; Pego-Reigosa JM
    Arthritis Care Res (Hoboken); 2020 Feb; 72(2):216-224. PubMed ID: 31529686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population.
    Khaliq W; Qayyum R; Clough J; Vaidya D; Wolff AC; Becker DM
    Breast Cancer Res Treat; 2015 Jun; 151(2):465-74. PubMed ID: 25957594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan.
    Ding DC; Chen W; Wang JH; Lin SZ
    Medicine (Baltimore); 2018 Sep; 97(39):e12608. PubMed ID: 30278576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.